
Mrs Oksana Obertynska
National Pirogov Memorial Medical University, Vinnitsa (Ukraine)
Membership:
ESC Professional Member
Follow
Biography
Obertynska Oksana was taking a postgraduate course at the department of cardiology. In 2007 she maintained the masters thesis in profession line -cardiology. She was working as cardiologist at the Military Hospital from 2001 till 20013. She has been working at department of propedeutics internal diseases of Vinnitsa Medical University from 2010 has been treating patients in the cardiology section. She delivers lectures and carries out practical studies with the third-year students of Medical faculty as well as with foreign students, carries out seminars with doctor-interns. She is an author of 18 scientific articles. Field of interests: cardiology, imaging, digital medicine.
Contributor content
Presentation
The impact of a chronic obstructive pulmonary disease diagnosis on the identification of heart failure
Presentation
The safety of in-hospital initiation of SGLT2 inhibitor with MRA therapy in patients hospitalized for heart failure with a reduced left ventricular ejection fraction and chronic kidney disease
Presentation
Safety and efficacy of initiation SGLT in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease on top of standard therapy with ARNI or ACE-i
Presentation
The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease
Presentation
Weight loss therapy in obese hypertensive patients: the effect of orlistat versus metformin
Presentation
The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease
Presentation
The efficacy and safety of mineralocorticoid-receptor antagonists: spironolactone and eplerenone in resistant hypertension and chronic kidney disease stages 3
Presentation
The relationship between plasma renin and aldosterone levels and the reduction of blood pressure with spironolactone in patients with resistant hypertension.
Presentation

